Given the recently published study of TQ vs PQ for P vivax relapse prevention, interesting to note the wide variation in treatment failure rates (0 to 32%) in these studies incl in the 2013 @cochranecollab review of PQ. Pharmacogenetics a likely factor? h
Primaquina para la prevención de la recaída en pacientes con paludismo por Plasmodium vivax tratado con cloroquina https://t.co/INSxui23qx
RT @CochraneLingual: Primaquine for preventing relapses in people with Plasmodium vivax malaria Tamil translation:https://t.co/pp9Ai8RDmx @…
Is treatment with 14-day primaquine more effective against vivax Malaria relapse than shorter primaquine courses?... http://t.co/abnNKjeKcc